Point72 Asset Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.83M Sell
137,611
-1,342,700
-91% -$30.3M ﹤0.01% 2084
2025
Q4
$35.1M Buy
1,480,311
+184,972
+14% +$4.5M 0.04% 574
2025
Q3
$32.3M Buy
+1,295,339
New +$27.9M 0.05% 377
2023
Q4
Sell
-43,387
Closed -$998K 2688
2023
Q3
$998K Sell
43,387
-587,823
-93% -$14.9M ﹤0.01% 1325
2023
Q2
$16.5M Sell
631,210
-2,663,290
-81% -$70.3M 0.05% 440
2023
Q1
$91M Buy
3,294,500
+1,321,319
+67% +$34.9M 0.28% 76
2022
Q4
$44.8M Buy
+1,973,181
New +$54.9M 0.15% 178
2022
Q3
Sell
-660,300
Closed -$19.2M 1672
2022
Q2
$19.2M Sell
660,300
-850,101
-56% -$21.6M 0.08% 321
2022
Q1
$40.4M Sell
1,510,401
-130,199
-8% -$3.07M 0.16% 179
2021
Q4
$42.4M Buy
+1,640,600
New +$40.9M 0.17% 163

Other funds holding PRVA

Point72 Asset Management's PRVA Position: Q1 2026 in Review

Point72 Asset Management reduced its Privia Health (PRVA) stake by 91% in Q1 2026, selling an estimated $30.3M and leaving 137,611 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2084.

Point72 Asset Management first reported a position in PRVA in Q4 2021 and has held it in 10 quarters since. The position peaked at $91M in Q1 2023. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Point72 Asset Management held 137,611 shares of Privia Health worth $2.83M as of Q1 2026.
  • Point72 Asset Management sold 1,342,700 Privia Health shares in Q1 2026, an estimated $30.3M.
  • Privia Health made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2084 holding.
  • Point72 Asset Management first reported a position in Privia Health in Q4 2021 and has held it in 10 quarters since.
  • Point72 Asset Management's Privia Health position peaked at $91M in Q1 2023.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.